BF

Bent Frandsen

Chief Executive Officer

ExpreS2ion Biotechnologies

Horsholm


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
ExpreS2ion Biotechnologies
Industry
biotechnology
Employees
22.0
Seniority
C suite
Annual Revenue
872000.0

Technologies

Outlook MailChimp SPF Woo Commerce Mobile Friendly Eventbrite YouTube WordPress.org Apache reCAPTCHA Cision Google Tag Manager Vimeo Google Font API Nginx

Keywords

drosophila s2 insect cells upstream process development process development for protein based vaccines discovery platform protein antigens cancer research vaccine development innovative vaccines svaccine candidates immunotherapy her2 cancer cancer vaccines infectious diseases clinical trials antigen delivery virus-like particle protein expression system expres2 platform protein synthesis high-quality antigens immune response safety & efficacy scalable production research partnerships clinical-stage biotechnology vaccine technology therapeutic vaccines prophylactic vaccines malaria vaccine cytomegalovirus vaccine cancer treatment immunogenicity biopharmaceuticals short development timelines patient outcomes quality control drug resistance vaccine candidates adjuvanted vaccines polyclonal antibody sustainable healthcare transforming healthcare drug management phase iii trials resilient communities infectious disease solutions investor partnerships clinical development proprietary technology therapeutic innovation healthcare advancements vaccine pipeline cancer immunotherapy health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans